TY  - JOUR

T1  - Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial

JO  - Journal of Dermatological Treatment

UR  - http://dx.doi.org/10.1080/09546634.2023.2200866

PY  - 2023/04/27

AU  - Flohr C

AU  - Cork MJ

AU  - Ardern-Jones MR

AU  - Eichenfield LF

AU  - Barbarot S

AU  - Feeney C

AU  - Rojo R

AU  - Lazariciu I

AU  - Nesnas J

ED  - 

DO  - DOI: 10.1080/09546634.2023.2200866

PB  - Informa UK Limited

VL  - 34

IS  - 1

Y2  - 2024/12/22

ER  -